Article
Measuring the health-related quality of life in HIV patients with integrase strand transfer inhibitor-based regimens in China
2024-07-18
Abstract excerpt
<title>Abstract</title> <p> Background With bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF), and dolutegravir/lamivudine (DTG/3TC) included in the national drug reimbursement list, the integrase strand transfer inhibitor (INSTI)-based regimens could be afforded and used by more patients. Majority of previous health-related quality of life (HRQoL) studies were conducted before INSTI-based regimens r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f1a9dbff-326b-57f8-9be8-c86361bd86f6
- DOI
- 10.21203/rs.3.rs-4635838/v1
